Bone Metastasis Therapeutics Market Size from 2022 to 2028 [MarketWatch]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: MarketWatch
Global " Bone Metastasis Therapeutics Market " report provides essential and detailed information about the global market. This report provides a comprehensive analysis and accurate statistics. It also includes company definition, key points, and total revenue. Bone Metastasis Therapeutics Market gives an overview of the market by market size, market coverage, market exchange rate, segmentation, and market share. This report analyses the current competitive environment in and provides basic information like market data, product introductions from leading companies in this industry. It also highlights the strategic analysis for Companies to Handle the impact of COVID-19. Bone Metastasis Therapeutics Market can be segmented by country, players, type, and application. The report will prove to be a valuable resource for players, stakeholders, and all other participants in the global Bone Metastasis Therapeutics Market. Segmental analysis is focused on revenue forecast and revenue forec
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for enfortumab vedotin with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer [Yahoo! Finance]Yahoo! Finance
- Harbour BioMed Reports Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Headlands Research Announces Fifth Research Site under Partnership with Pfizer to Improve Diversity in Clinical Trials [Yahoo! Finance]Yahoo! Finance
- Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023 [Yahoo! Finance]Yahoo! Finance
- Global Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developments [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 3/18/24 - Form 4
- 3/18/24 - Form 4
- 3/14/24 - Form ARS
- PFE's page on the SEC website